Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-22-025528
Filing Date
2022-09-09
Accepted
2022-09-09 17:21:52
Documents
7

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 562569
2 ex4-5.htm EX-4.5 417393
3 ex5-1.htm EX-5.1 49440
4 ex10-1.htm EX-10.1 295450
5 ex23-1.htm EX-23.1 5759
6 ex107.htm EX-FILING FEES 49928
7 forms-3_001.jpg GRAPHIC 10011
  Complete submission text file 0001493152-22-025528.txt   1395586
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: S-3 | Act: 33 | File No.: 333-267369 | Film No.: 221236907
SIC: 2834 Pharmaceutical Preparations